APA (7th ed.) Citation

Passweg, J., Labopin, M., Christopeit, M., Cornelissen, J., Pabst, T., Socié, G., . . . Nagler, A. (2020). Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of Blood & Marrow Transplantation, 26(4), 659. https://doi.org/10.1016/j.bbmt.2019.11.021

Chicago Style (17th ed.) Citation

Passweg, J.R, et al. "Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." Biology of Blood & Marrow Transplantation 26, no. 4 (2020): 659. https://doi.org/10.1016/j.bbmt.2019.11.021.

MLA (9th ed.) Citation

Passweg, J.R, et al. "Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." Biology of Blood & Marrow Transplantation, vol. 26, no. 4, 2020, p. 659, https://doi.org/10.1016/j.bbmt.2019.11.021.